Scientists are concerned about the emergence of SARS-CoV-2 variants and whether existing vaccines will remain effective against them. Hence, the development of robust therapeutic systems, such as repurposing drugs, could aid in managing the pandemic more efficiently. This article discusses the different vaccines and potential treatments developed thus far.
Universities and transmission of knowledge a Covid challenge
Covid-19 posed a challenge to human intellect all over the globe
The writer is a practising lawyer. He holds PHD in Political Science and heads a think-tank ‘Good Governance Forum’. He can be reached at [email protected]
Universities, high centers of excellence and institutes the world over are considered to be the repository of knowledge and vehicles for transmission of such knowledge. Community colleges also impart knowledge but the major difference between the two is that while colleges usually pass instructions in the form of lectures, universities, centres and institutes are known for their research and introduction of new products.
Oxfordâs malaria vaccine shows significant 75% efficacy in early trial
Oxfordâs malaria vaccine shows significant 75% efficacy in early trial 04 May 2021 | News Being the first malaria vaccine candidate to meet WHO standards, the collaborative efforts of Novavax and Serum Institute of India (SII) aims to produce 200 million doses annually upon further safety and efficacy results
Photo Credit: Freepik
A malaria vaccine created by scientists at the University of Oxford’s Jenner Institute has been found to be 77% effective in early-stage trials. It is the first malaria vaccine to meet the WHO’s target of 75%.
The Phase IIb trial of the vaccine candidate, R21, enrolled 450 children in Burkina Faso, a country in West Africa.
Will Covid kick malaria out of the global bucket list?
Michael Jennings Filed on May 3, 2021
Malaria is an example of where the needs of the Global South, or developing world, clash against the interests of the Global North, or developed world.
Lost in the deluge of news about Covid-19 vaccines have been the momentous strides made recently in fighting other major health challenges. Among these is malaria. In April, it was announced that a vaccine developed at the University of Oxford’s Jenner Institute had achieved 77 per cent efficacy in trials. While we may still be several years from an effective guard against a disease that afflicts over 200 million people each year, there is a sense that we’re significantly closer to that goal than ever before. Yet, the vaccine’s very potential to successfully eradicate malaria could, perversely, undercut the support necessary to achieve reality. Malaria is an example of where the needs of the Global South, or developing worl
Opinion | In putting out the blaze of the pandemic, we can t forget other raging diseases washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.